It was reported through a research presentation identifying absorb bvs and xience stents that may be related to the following: myocardial infarction, thrombosis, revascularization, rehospitalization.
Deployment difficulty was also noted for both absorb bvs and xience stents.
This article summarizes clinical outcomes of 1,845 patients that were treated with xience stents.
Specific patient information is documented as unknown.
Details are listed in the article, titled "the relationship of pre-procedural dmax based sizing to lesion level outcomes in absorb bvs and xience ees treated patients in the aida trial.
".
|